Showing results (371-380 of 782) with videos related to
Sort By:
Pageof 79
Pharmaceuticals (Basel, Switzerland)|October 8, 2016
Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?Paolo Cravedi, Varusca Brusegan, Piero Ruggenenti, et al.Pediatric Nephrology (Berlin, Germany)|October 6, 2016
Achieving remission of proteinuria in childhood CKDPiero Ruggenenti, Paolo Cravedi, Antonietta Chianca, et al.American Journal of Physiology. Renal Physiology|December 25, 2015
Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?Rubina Novelli, Elena Gagliardini, Barbara Ruggiero, et al.Blood|April 20, 2006
Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcomeJessica Caprioli, Marina Noris, Simona Brioschi, et al.Blood|April 25, 2012
Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpuraLuca A Lotta, Haifeng M Wu, Ian J Mackie, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2009
The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney graftsMarina Noris, Paola Cassis, Nadia Azzollini, et al.Clinical Journal of the American Society of Nephrology : CJASN|July 3, 2010
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotypeMarina Noris, Jessica Caprioli, Elena Bresin, et al.Clinical Journal of the American Society of Nephrology : CJASN|February 26, 2016
Effect of Sirolimus on Disease Progression in Patients with Autosomal Dominant Polycystic Kidney Disease and CKD Stages 3b-4Piero Ruggenenti, Giorgio Gentile, Norberto Perico, et al.Journal of the American Society of Nephrology : JASN|May 15, 2010
Sirolimus therapy to halt the progression of ADPKDNorberto Perico, Luca Antiga, Anna Caroli, et al.Transplantation|September 11, 2009
Toward MSC in solid organ transplantation: 2008 position paper of the MISOT study groupMarc H Dahlke, Martin Hoogduijn, Elke Eggenhofer, et al.Pageof 79